Advanced Cell Technology, Inc.Worcester, MA, United States (OTC: ACTC)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Advanced Cell Technology Financial Statements

Advanced Cell Technology Financial Information

Company Type Public
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Advanced Cell Technology Stock Quote & Chart

11/06/09 15:59:57 EST • NASDAQ OTC BB • 0.10 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Advanced Cell Technology Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 40.98 7.55 7.01
Price/Earnings Ratio (0.63) 93.46 25.51
Price/Book Ratio (0.68) 3.48 6.74
Price/Cash Flow Ratio (36.90) 41.49 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Advanced Cell Technology Financial Ratios

Advanced Cell Technology Competitive Intelligence

Genzyme Geron StemCells
Annual Sales ($ mil.) 4,605.0 2.8 0.2
Employees 11,000 159 55
Market Cap ($ mil.) 13,874.2 502.1 133.7

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy